ArticleThe Lancet regional health. Europe2025

Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trial.

Thomas Gaziano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.